|
|
||||||||
Journal of Lipid Research, Vol 27, 1190-1204, Copyright © 1986 by Lipid Research, Inc.
SR Panini, RC Sexton, AK Gupta, EJ Parish, S Chitrakorn and H Rudney
Treatment of rat intestinal epithelial cell cultures with the oxidosqualene
cyclase inhibitor, 3 beta-[2-(diethylamino)- ethoxy]androst-5-en-17-one
(U18666A), resulted in an accumulation of squalene 2,3:22,23-dioxide (SDO).
When U18666A was withdrawn and the cells were treated with the sterol 14
alpha-demethylase inhibitor, ketoconazole, SDO was metabolized to a product
identified as 24(S),25- epoxylanosterol. To test the biological effects and
cellular metabolism of this compound, we prepared 24(RS),25-epoxylanosterol
by chemical synthesis. The epimeric mixture of 24,25-epoxylanosterols could
be resolved by high performance liquid chromatography on a wide-pore, non-
endcapped, reverse phase column. Both epimers were effective suppressors of
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity of IEC-6
cells. The suppressive action of the natural epimer,
24(S),25-epoxylanosterol, but not that of 24(R),25- epoxylanosterol could
be completely prevented by ketoconazole. IEC-6 cells could efficiently
metabolize biosynthetic 24(S),25- epoxy[3H]anosterol mainly to the known
reductase-suppressor 24(S),25- epoxycholesterol. This metabolism was
substantially reduced by ketoconazole. These data support the conclusion
that 24(S),25- epoxylanosterol per se is not a suppressor of HMG-CoA
reductase activity but is a precursor to a regulatory oxysterol(s). It has
recently been reported that 25-hydroxycholesterol can occur naturally in
cultured cells in amounts sufficient to effect regulation of HMG-CoA
reductase (Saucier et al. 1985. J. Biol. Chem. 260: 14571-14579). In order
to investigate the biological effects of possible precursors of
25-hydroxycholesterol, we chemically synthesized 25-hydroxylanosterol and
25-hydroxylanostene-3-one. Both oxylanosterol derivatives suppressed
cellular sterol synthesis at the level of HMG-CoA reductase. U18666A had
the unusual effect of potentiating the inhibitory effect of
25-hydroxylanostene-3-one but did not influence the effect of other
oxylanosterols. All the oxylanosterols, with the exception of 25-
hydroxylanostene-3-one, enhanced intracellular esterification of
cholesterol. The foregoing observations support consideration of
oxylanosterols as playing an important role in the biological formation of
regulatory oxysterols that modulate sterol biosynthesis at the level of
HMG-CoA reductase.
ARTICLES
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis by oxylanosterols
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Wong, C. M. Quinn, I. C. Gelissen, and A. J. Brown Endogenous 24(S),25-Epoxycholesterol Fine-tunes Acute Control of Cellular Cholesterol Homeostasis J. Biol. Chem., January 11, 2008; 283(2): 700 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Gardner, H. Shan, S. P. T. Matsuda, and R. Y. Hampton An Oxysterol-derived Positive Signal for 3-Hydroxy- 3-methylglutaryl-CoA Reductase Degradation in Yeast J. Biol. Chem., March 16, 2001; 276(12): 8681 - 8694. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |